Skip to content

The effects of capsaicin and tea on sodium and water homeostasis as measured by osmoregulation and blood pressure.

The effects of capsaicin and tea on sodium and water homeostasis as measured by osmoregulation and blood pressure. - PEPPER study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON40691
Enrollment
24
Registered
2014-12-24
Start date
2015-01-23
Completion date
Unknown
Last updated
2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hyponatremia syndrome of inappropriate antidiuresis

Interventions

Capsaicin and tea (flavonoids) will be administered to examine the effects on osmoregulation, kidney function and blood pressure with and without a concurrent water load (WL). For the WL, 20mL/kg wa

Sponsors

Academisch Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Male between 18 and 40 years of age - Healthy as determined by a responsible and experienced physician, based on a medical evaluation, including medical history, physical examination (PE) and laboratory tests carried out in the screening visit. - Non-treated office blood pressure *135/85 mmHg - Body Mass Index (BMI) * 30kg/m2 - Capable of giving written informed consent and able to comply with the requirements and restrictions listed in the informed consent form.

Exclusion criteria

Exclusion criteria: * An office blood pressure * 135/85 mmHg * A body mass index * 30 kg/m2 * unwillingness to quit temporally being exposed to spicy food * A major illness in the past 3 months or any significant chronic medical illness that the investigator would deem unfavourable for enrolment, including chronic inflammatory diseases. * A history of any type of malignancy within the past 5 years with the exception of succesfully treated basal cell carcinoma of the skin. * A history of any renal disease * A history of any blood clotting disorders * A history of any auto-immune disease * A history of cardiovascular disease (in the past 6 months) defined as documented coronary artery disease including myocardial infarction (MI), (un-)stable angina pectoris or acute coronary syndrome (ACS), precutenaous transluminal coronary angioplasty (PTCA), coronary artery bypass grafting (CABG), cerebrovascular disease, including ischaemic and hemorrhagic stroke or a subarachnoidal bleeding (SAB), or peripheral artery disease, including aortic aneurysmata (AA). * A history, within three years, of drugs abuse, including benzodiazepines, opioids, amphetamines, cocain and Cannabis (THC). * A history of alcoholism and/or drinking more than 3 units of alcohol per day. Alcoholism is defined as an average weekly intake > 21 units for males. One unit is equivalent to 8 g Of alcohol: a half-pint (240mL of beer), 1 glass (125mL) of wine or one measure (25mL) of hard liquor. * Smoking or usage of tabacco products less than 30 days ago. * Any other issue that in opinion of the investigator could be harmful to the subject or comprise interpretation of data.

Design outcomes

Primary

MeasureTime frame
The primary endpoint is the control period-subtracted change in serum sodium induced after an oral administration of capsaicin or tea, with and without WL.

Secondary

MeasureTime frame
Secondary endpoints hold plasma osmolality, co-peptin, vasopressin (AVP), RAAS hormones as well as urinary volume, urinary sodium excretion, and urinary osmolality. Also, blood pressure, body weight and body temperature will be measured.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)